vyvanse

Generic: lisdexamfetamine dimesylate

Labeler: takeda pharmaceuticals america, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vyvanse
Generic Name lisdexamfetamine dimesylate
Labeler takeda pharmaceuticals america, inc.
Dosage Form TABLET, CHEWABLE
Routes
ORAL
Active Ingredients

lisdexamfetamine dimesylate 30 mg/1

Manufacturer
Takeda Pharmaceuticals America, Inc.

Identifiers & Regulatory

Product NDC 59417-117
Product ID 59417-117_78225b65-2133-4c6c-bfde-0f2b26e5b19f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA208510
DEA Schedule cii
Listing Expiration 2026-12-31
Marketing Start 2017-01-28

Pharmacologic Class

Classes
central nervous system stimulant [epc] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59417117
Hyphenated Format 59417-117

Supplemental Identifiers

RxCUI
854830 854832 854834 854836 854838 854840 854842 854844 854846 854848 854850 854852 1593856 1593858 1871456 1871459 1871460 1871461 1871462 1871463 1871464 1871465 1871466 1871467 1871468 1871469
UNII
SJT761GEGS

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vyvanse (source: ndc)
Generic Name lisdexamfetamine dimesylate (source: ndc)
Application Number NDA208510 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 100 TABLET, CHEWABLE in 1 BOTTLE (59417-117-01)
source: ndc

Packages (1)

59417-117-01 100 TABLET, CHEWABLE in 1 BOTTLE (59417-117-01)

Ingredients (1)

lisdexamfetamine dimesylate (30 mg/1)

Linked Drug Pages (1)

Vyvanse ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "78225b65-2133-4c6c-bfde-0f2b26e5b19f", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854832", "854834", "854836", "854838", "854840", "854842", "854844", "854846", "854848", "854850", "854852", "1593856", "1593858", "1871456", "1871459", "1871460", "1871461", "1871462", "1871463", "1871464", "1871465", "1871466", "1871467", "1871468", "1871469"], "spl_set_id": ["704e4378-ca83-445c-8b45-3cfa51c1ecad"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (59417-117-01)", "package_ndc": "59417-117-01", "marketing_start_date": "20170128"}], "brand_name": "Vyvanse", "product_id": "59417-117_78225b65-2133-4c6c-bfde-0f2b26e5b19f", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "59417-117", "dea_schedule": "CII", "generic_name": "LISDEXAMFETAMINE DIMESYLATE", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vyvanse", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "30 mg/1"}], "application_number": "NDA208510", "marketing_category": "NDA", "marketing_start_date": "20170128", "listing_expiration_date": "20261231"}